Kelly Ferrara
Nurse Practitioner · Daytona Beach, FLNPI 1598326571
Payments from drug & device makers
Across 278 payments — averaging $21.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$659
- Xeris Pharmaceuticals, Inc.$633
- AbbVie$506
- Radius Health, Inc.$447
- IBSA Pharma Inc.$418
- Lilly USA, LLC$339
- plus $3K from 32 others
What the payments were for
- Food & beverage$5,927100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 32 | $659 |
| Xeris Pharmaceuticals, Inc. | 38 | $633 |
| AbbVie | 21 | $506 |
| Radius Health, Inc. | 18 | $447 |
| IBSA Pharma Inc. | 18 | $418 |
| Lilly USA, LLC | 18 | $339 |
| Bayer | 12 | $321 |
| Amgen(2 entities) | 18 | $300 |
| Medtronic | 11 | $235 |
| Boehringer Ingelheim | 10 | $213 |
| Dexcom, Inc. | 6 | $184 |
| Tandem Diabetes Care, Inc. | 6 | $169 |
| Abbott | 7 | $151 |
| BETA Bionics, Inc. | 6 | $134 |
| Amneal Pharmaceuticals LLC | 8 | $129 |
| Tolmar, Inc. | 7 | $122 |
| Astellas Pharma US Inc | 6 | $115 |
| Johnson & Johnson | 1 | $98 |
| Corcept Therapeutics | 4 | $82 |
| Sanofi-aventis U.S. LLC | 3 | $75 |
| Alvogen Inc | 4 | $69 |
| Recordati_rare_diseases_inc. | 3 | $58 |
| Ascendis Pharma Endocrinology Inc | 2 | $50 |
| Neurocrine Biosciences, Inc. | 2 | $50 |
| Amarin Pharma, Inc. | 2 | $47 |
| Ascensia Diabetes Care US Inc. | 2 | $42 |
| Sequel Med Tech, LLC | 1 | $34 |
| Novartis | 2 | $34 |
| AstraZeneca | 1 | $33 |
| Almatica Pharma LLC | 1 | $25 |
| Mannkind Corporation | 1 | $25 |
| Averitas Pharma Inc. | 1 | $24 |
| Madrigal Pharmaceuticals | 1 | $23 |
| Cequr Corporation | 1 | $19 |
| Kyowa Kirin, Inc. | 1 | $18 |
| Esperion Therapeutics, Inc. | 1 | $16 |
| Acella Pharmaceuticals, LLC | 1 | $16 |
| GSK | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,927 in reported general payments places this provider in the 90th percentile of 8,290 nurse practitioner providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 206 | $281,199 |
| JardianceEmpagliflozin | 220 | $264,352 |
| MounjaroTirzepatide | 157 | $220,988 |
| RybelsusSemaglutide | 47 | $78,150 |
| Tresiba Flextouch U-200Insulin Degludec | 58 | $76,352 |
| Soliqua 100-33Insulin Glargine/Lixisenatide | 37 | $62,531 |
| FarxigaDapagliflozin Propanediol | 49 | $55,781 |
| Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog | 37 | $53,241 |
| TrulicityDulaglutide | 21 | $33,182 |
| Humulin R U-500 KwikpenInsulin Regular, Human | 11 | $24,862 |
| Janumet XrSitagliptin Phos/Metformin Hcl | 12 | $18,520 |
| SynthroidLevothyroxine Sodium | 99 | $10,909 |
| Repatha SureclickEvolocumab | 11 | $7,803 |
| NovologInsulin Aspart | 11 | $7,772 |
| InvokanaCanagliflozin | 11 | $6,326 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus, Novolog | $659 | $367,121264 claims |
| Boehringer IngelheimJardiance | $213 | $264,352220 claims |
| Lilly USA, LLCMounjaro, Trulicity | $339 | $254,170178 claims |
| Sanofi-aventis U.S. LLCSoliqua 100-33, Lantus | $75 | $66,81352 claims |
| AstraZenecaFarxiga | $33 | $55,78149 claims |
| AbbVieSynthroid | $506 | $10,90999 claims |
| Johnson & JohnsonInvokana | $98 | $6,32611 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium, Unithroid | $129 | $4,261324 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 8,290 nurse practitioner providers in Florida.
Other nurse practitioner in Daytona Beach
- Jolanta BaginskiClearwater$494K
- Adissa PerezWinter Park$370K
- April WessonTampa$342K
- Margarita FernandezMiami$311K
- Stephanie SimmermanNaples$283K
- Claudette WalkerPonte Vedra Beach$271K
- Lisa NodzonTampa$246K
- Ashima BahlTampa$226K
- Maya BloombergMiami$202K
- Jennifer PuleoTampa$171K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.